Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eaasCduTtWCfdPfECidncVCicNFQuL
| Today's Top Story |  |  | | | Health Care & Policy | | | | - TG licenses cancer drug candidate to South Korean firm
TG Therapeutics granted Ildong Pharmaceutical exclusive rights to develop and market ublituximab, or TGTX-1101, for all indications in South Korea and Southeast Asia. Ublituximab, an anti-CD20 antibody, is being developed as a treatment for hematologic malignancies and other B-cell lymphoproliferative diseases. The deal entitles TG Therapeutics to $2 million upfront plus milestone and royalty fees based on sales. Genetic Engineering & Biotechnology News (11/15)       - Gene mutation might triple the risk for Alzheimer's
A mutation in a gene involved in immune and inflammatory responses might put carriers at triple the risk for Alzheimer's disease compared with people who do not carry the mutation, according to a study published in the New England Journal of Medicine. The TREM2 mutation is rare, but people age 85 or older who do have it are nearly seven times more likely to have Alzheimer's disease than their peers who do not have the mutation, researchers found. The mutation might be a new drug target, the lead researcher said. HealthDay News (11/14), Reuters (11/14) - Pancreatic stem cells show promise for type 1 diabetes
Australian researchers have identified pancreatic stem cells that can be converted into insulin-producing cells and found that the cells' number and capacity to become insulin-producers also appeared to increase in response to pancreatic damage. The findings in PLoS ONE may pave the way for new type 1 diabetes treatments, researchers said. Medical News Today (11/14) | Company & Financial News | | | | | Food & Agriculture | | | | - Researchers look at biofuel potential of "energy beets"
Researchers from North Dakota State University and beet seed company Betaseed are looking into the economic viability of using "energy beets" as an ethanol feedstock. The research is part of the BeetsAll Biofuel project, a partnership between North Dakota-based Green Vision Group and Iowa-based Heartland Renewable Energy. Construction of the first beet-to-ethanol plant is scheduled to begin in late 2013 or early 2014. Ag Professional online (11/14) | Industrial & Environmental | | | | - FuturaGene CEO: Biotech eucalyptus trees can replace fossil fuels
FuturaGene has developed biotech eucalyptus trees that grow 40% faster than normal eucalyptus, making it possible for them to be used for energy generation. "Potentially, we believe this [development] can displace the whole fossil fuel industry. The technology can be adapted to any trees. We can have a whole new supply of fuel," CEO Stanley Hirsch said. Hirsch said the company is working to obtain regulatory approval to commercially grow the trees in Brazil. The Guardian (London) (11/15)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | One thing I am convinced more and more is true and that is this: The only way to be truly happy is to make others happy. When you realize that and take advantage of the fact, everything is made perfect."
--William Carlos Williams,
American poet and physician  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Thursday, November 15, 2012
- Wednesday, November 14, 2012
- Tuesday, November 13, 2012
- Monday, November 12, 2012
- Friday, November 09, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment